The investigators found that low levels of ADGRF5 in highly metastatic cancer cells inhibited cell migration and invasion in vitro, whereas ectopic ADGRF5 expression in low metastatic cells had the opposite effect. This evidence concerns the gene ADGRF5 and cancer.